Public Allergy Drug Improves Function in Patients with Chronic Injury from Multiple Sclerosis

Adrian · Oct 25, 2017

e

In a remarkably rapid translation of laboratory research findings into a treatment with the potential to benefit patients, UC San Francisco scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic multiple sclerosis (MS)

In light of previous laboratory studies of the antihistamine compound at UCSF, the researchers said, the drug most likely exerted its effect by repairing damage MS had inflicted on myelin, an insulating membrane that speeds transmission of electrical signals in the nervous system
Click to expand...

I don't think this has much interest for ME because they are talking about repairing Myelin. But I think it is a good example of drug re purposing.

https://www.ucsf.edu/news/2017/10/4...on-patients-chronic-injury-multiple-sclerosis

Log in or Sign up

Public Allergy Drug Improves Function in Patients with Chronic Injury from Multiple Sclerosis

Adrian Administrator Staff Member

Share This Page

Log in or Sign up

Public Allergy Drug Improves Function in Patients with Chronic Injury from Multiple Sclerosis

Adrian Administrator Staff Member

Share This Page

Useful Searches